Search results
22 paź 2024 · Technologies that advance the availability of radiopharmaceuticals are increasingly critical for the treatment of cancer. NorthStar’s patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO/CMO) addresses this important need. Learn More
- Development
NorthStar is ideally positioned to help pharmaceutical...
- Therapeutics
At NorthStar, we remain committed to our mission of...
- CDMO/CMO
NorthStar Medical Radioisotopes is a leader in novel, ......
- Company
NorthStar is a radiopharmaceutical company, developing novel...
- Careers
The Radiopharmaceutical Manufacturing Specialist performs...
- Manufacturing
NorthStar’s Radiopharmaceutical CDMO/CMO unit offers...
- Pipeline
We are developing commercial-scale production technologies...
- Development
At NorthStar, we remain committed to our mission of providing patients global access to game-changing radiopharmaceuticals with commercial scale production of actinium-225 (Ac-225) and copper-67 (Cu-67) that have the potential to improve cancer treatment outcomes.
NorthStar is a radiopharmaceutical company, developing novel ways to help detect and cure cancer and other serious diseases. We are the first and only U.S. company housing commercial scale radioisotope production and radiopharmaceutical CDMO services co-located on the same campus.
At NorthStar Medical Radioisotopes, our mission is to provide patients global access to game-changing radiopharmaceuticals. We are a growing, commercial-stage company focused on advancing...
14 paź 2021 · NorthStar Medical Radioisotopes is the sole commercial U.S. producer of the important medical radioisotope molybdenum-99 (Mo-99), and the only company in the world to use environmentally...
3 kwi 2023 · NorthStar Medical Radioisotopes is a global innovator in radiopharmaceuticals for medical imaging and therapy. Learn about its progress and upcoming milestones in Mo-99, Cu-67, Ac-225, CDMO/CMO services and imaging programs.
29 mar 2022 · NorthStar Medical Radioisotopes is a global innovator in radiopharmaceuticals for medical imaging and therapy. The company provides updates on its progress and upcoming milestones for domestic, environmentally sustainable production of Mo-99, Ac-225, Cu-67 and other radioisotopes.